Bavarian Nordic A/S: publication of offer document in respect
Bavarian Nordic A/S, a Danish biotechnology company, is set to see a significant development with the upcoming publication of an offer document. The consortium led by Nordic Capital and Permira has announced an all-cash recommended voluntary public takeover offer for Bavarian Nordic at DKK 233.0 per share [1]. The offer document, as approved by the Danish Financial Supervisory Authority, is expected to be published as soon as possible but no later than August 26, 2025.
The Board of Directors of Bavarian Nordic has deemed the offer from Nordic Capital and Permira to be attractive for shareholders and has unanimously decided to recommend acceptance of the offer. The detailed reasons for this recommendation will be included in a reasoned statement on the offer, which will be published alongside the offer document on the company's website.
The consortium, which includes Nordic Capital and Permira, has incorporated and controls Innosera ApS, the legal entity that will publish the offer document once approved by the Danish FSA. Maria Montserrat Montaner Picart, affiliated with Nordic Capital, did not participate in the Board of Directors' deliberations or the handling of the transactions.
Investors and financial professionals are advised to keep an eye on the Bavarian Nordic website for the publication of the offer document and the reasoned statement on the offer. The offer represents a significant event that could impact the company's share price and future prospects.
References:
[1] https://www.bavarian-nordic.com/investor/takeover-offer/
Comments
No comments yet